Aeonose


The eNose Company is a medical-technical company that has developed the Aeonose, which is able to ‘smell’ diseases quickly and effectvely using sensor technology. The Aeonose uses metal oxide sensors, comparable to sensors in the car industry that detect exhaust gas. The device smells, based on substances in the exhaled air, whether the patient has a disease. Exhaled air contains a large number (>1,500) of different volatile organic compounds (VOCs). These create a representation (breath profile) of the human body’s metabolism. Such a breath profile consists of a lot of data, and is analysed in order to recognise patterns. By analysing many breath patterns, you can ‘train’ an algorithm, and can run an unknown breath profile through it. It will then immediately provide you with a diagnosis.

Target population
Not specified or other
Development Year
2013
Aandoeningscategorie
Cancer
Get going

Characteristics

Edition
Healthcare Enablers 2020
The eNose Company
Trend
Enhanced Diagnostics
Sector
Hospital care
Aim
Other
Phase
Diagnosis
Technology type
(Self)Tests
Artificial Intelligence (AI)
Conditionion
Colon and bowel cancer
Lung cancer